Biopsomic
Genève, Switzerland
Biopsomic is developing a new liquid biopsy for cancer prognosis.From a simple blood draw, our non-invasive test probes the actual disease state and evaluates the risk of developing metastatic disease based on the analysis of nanovesicles called exosomes.These new insights allow oncologists to make proper well-informed clinical decisions and ensure optimal outcomes for patients.We are currently looking for new team members.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- bioalps.org/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Biopsomic?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now